ATI RN
ATI N211 Pharmacology Exam Questions
Question 1 of 5
A nurse is reviewing a client's admission record. The nurse notes that there are prescriptions for several medications. Which of the following factors should the nurse recognize is of primary consideration when determining the schedule of administration?
Correct Answer: C
Rationale: The correct answer is C: Specific characteristics of the medications. When determining the schedule of administration, the nurse must consider factors such as medication absorption, peak action times, and interactions with other medications. This ensures optimal therapeutic effects and minimizes adverse reactions. Institutional policies (
A) may provide guidelines but do not override individual medication needs. Pharmacy availability (
B) is important but does not dictate the timing of administration. The client's home schedule (
D) may not align with optimal medication timing.
Question 2 of 5
A charge nurse is supervising a newly licensed nurse provide care for a client who has a PCA pump. Which of the following statements made by the nurse requires further action by the charge nurse?
Correct Answer: D
Rationale: The correct answer is D. Discarding the remaining medication from the PCA pump without a witness is incorrect as it violates the principle of two-person verification for medication safety. The charge nurse must ensure proper documentation and witness the disposal to prevent medication errors.
Choice A is incorrect as bolus doses are allowed during PCA initiation.
Choice B is also acceptable, as the lockout period is within the appropriate range.
Choice C is incorrect as family education on PCA use is essential. Thus,
Choice D requires further action due to the lack of proper witness verification during medication disposal.
Question 3 of 5
A nurse is teaching a client who has bipolar disorder and a prescription for lithium to recognize the manifestations of toxicity. Which of the following statements by the client indicates an understanding of the teaching?
Correct Answer: A
Rationale: The correct answer is A: Vomiting is an indication of toxicity. Lithium toxicity commonly presents with gastrointestinal symptoms such as nausea, vomiting, and diarrhea. This statement indicates that the client understands a crucial sign of lithium toxicity.
Choice B, increased flatulence, is not a typical manifestation of lithium toxicity. Headaches (choice
C) are more commonly seen in cases of lithium overdose, not just toxicity. Loss of appetite (choice
D) is a symptom of lithium toxicity, but vomiting is a more specific and immediate indication.
Question 4 of 5
A nurse is teaching a client who has been taking prednisone to treat asthma and has a new prescription to discontinue the medication. The nurse should explain to the client to reduce the dose gradually to prevent which of the following adverse effects?
Correct Answer: B
Rationale: The correct answer is B: Adrenocortical insufficiency. When a client abruptly stops taking prednisone, it can suppress the adrenal gland's ability to produce cortisol, leading to adrenocortical insufficiency. Gradually reducing the dose allows the adrenal glands time to resume cortisol production, preventing this adverse effect. Rebound pulmonary congestion (choice
A) is not directly related to discontinuing prednisone. Severe dehydration (choice
C) and hyperglycemia (choice
D) are not typically associated with discontinuing prednisone but rather with other factors.
Question 5 of 5
A nurse is evaluating teaching on a client who has a new prescription for montelukast to treat asthma. Which of the following statements by the client indicates an understanding of the teaching?
Correct Answer: A
Rationale: The correct answer is A: "I'll take this medication once a day in the evening." This is correct because montelukast is usually taken once daily in the evening to prevent asthma symptoms. Option B is incorrect because montelukast is not a rescue medication for immediate asthma attacks. Option C is related to inhaler use, not montelukast. Option D is more relevant to corticosteroid inhalers.